NASDAQ · MGRX

Mangoceuticals, Inc.

Closing price · Nov 13, 2026 $0.155

Latest quarter · ended Jun 30, 2026

Sales slipped and cash got weaker

descriptionFiled Aug 13, 2026
Revenue growthShrinking
−59.1%
Quarter ended Sep 30, 2024: −45.6% sales vs. a year beforeQuarter ended Dec 31, 2024: −56.9% sales vs. a year beforeQuarter ended Mar 31, 2025: −48.9% sales vs. a year beforeQuarter ended Jun 30, 2025: +3.0% sales vs. a year beforeQuarter ended Sep 30, 2025: −36.8% sales vs. a year beforeQuarter ended Dec 31, 2025: −10.3% sales vs. a year beforeQuarter ended Mar 31, 2026: −37.9% sales vs. a year beforeQuarter ended Jun 30, 2026: −59.1% sales vs. a year before
Sep '24Jun '26
$68.8K vs. $168K a year ago
Gross marginBetter
64.3%
Quarter ended Sep 30, 2024: 62.0% gross marginQuarter ended Dec 31, 2024: 76.1% gross marginQuarter ended Mar 31, 2025: 56.8% gross marginQuarter ended Jun 30, 2025: 53.5% gross marginQuarter ended Sep 30, 2025: 60.4% gross marginQuarter ended Dec 31, 2025: 50.3% gross marginQuarter ended Mar 31, 2026: 42.7% gross marginQuarter ended Jun 30, 2026: 64.3% gross margin
Sep '24Jun '26
vs. 53.5% a year ago
Cash from operationsBetter
−$261K
Quarter ended Sep 30, 2024: −$1.17M cash from operationsQuarter ended Dec 31, 2024: −$1.13M cash from operationsQuarter ended Mar 31, 2025: −$2.27M cash from operationsQuarter ended Jun 30, 2025: −$1.26M cash from operationsQuarter ended Sep 30, 2025: −$1.24M cash from operationsQuarter ended Dec 31, 2025: −$1.08M cash from operationsQuarter ended Mar 31, 2026: −$1.31M cash from operationsQuarter ended Jun 30, 2026: −$261K cash from operations
Sep '24Jun '26
vs. −$1.26M a year ago
Share countDiluting
+104.7%
Quarter ended Sep 30, 2024: 2.49M sharesQuarter ended Dec 31, 2024: 5.17M sharesQuarter ended Mar 31, 2025: 11.03M sharesQuarter ended Jun 30, 2025: 10.54M sharesQuarter ended Sep 30, 2025: 13.91M sharesQuarter ended Dec 31, 2025: 16.97M sharesQuarter ended Mar 31, 2026: 17.17M sharesQuarter ended Jun 30, 2026: 21.57M shares
Sep '24Jun '26
21.57M shares vs. 10.54M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    3 real insider sales in 12 months. $21.2K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

19 funds report owning MGRX, up from 18

Holdings as of Jun 30, 2026
New6
Added1
Held11
Trimmed1
Sold out5

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Jul 28 · 2M shStock grant · Jul 28 · 100,000 shStock grant · Jul 28 · 100,000 shGift · Aug 11 · 4M shOpen-market sale · Dec 5 · $11.3KOpen-market sale · Dec 9 · $6KOpen-market sale · Dec 15 · $3.9K
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Jul 28 · 2M shStock grant · Jul 28 · 100,000 shStock grant · Jul 28 · 100,000 shGift · Aug 11 · 4M shOpen-market sale · Dec 5 · $11.3KOpen-market sale · Dec 9 · $6KOpen-market sale · Dec 15 · $3.9K

Last 12 months. No real trades in the last 6.

Showing 3 real trades. Hidden: 3 stock grants, 1 gift. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Dec 15 Eugene Johnston CFO Open-market sale $3.9K 3,333 sh at $1.17 Sold 3% of stake
Dec 9 Eugene Johnston CFO Open-market sale $6K 5,000 sh at $1.20 Sold 4% of stake
Dec 5 Eugene Johnston CFO Open-market sale $11.3K 10,000 sh at $1.13 Sold 7% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in MGRX

As of Jun 30, 2026
FundOwnsValueChange
Citadel Advisors LLC1.6%$129KNew
XTX Topco Ltd0.9%$70.8K+1317%
Geode Capital Management, LLC0.7%$59.4K−20%
Ikarian Capital, LLC0.6%$52.5KSame
Vanguard Capital Management LLC0.6%$46.8KSame

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist